أخبار عاجلة
EdiGene Announces First Patient Enrolment In Phase I Clinical Trial Of Gene-editing Therapy ET-01 For Patients With β-Thalassaemia
TIF Hosting A New Series Of Webinars For TIF Member Associations And T-PAG Members
TIF Position Statement: Demanding Access To Existing And Upcoming Gene Therapies For β-Thalassaemia
TIF Issues Charter of Priorities (CoP) For The Global PKD Patient Community
Mitapivat Granted Priority Review By The FDA For Pyruvate Kinase (PK) Deficiency
TIF Presents The Federation’s Annual Report For 2020
CDC, FDA Authorize Third Dose Of COVID-19 Vaccines For The Immunocompromised In The US
TIF e-Academy: Reimagining Thalassaemia and Sickle Cell Disease Education
Gene Therapy
Gene Editing
English
Ελληνικά
Français
Italiano
القائمة
بحث عن
404 :(
المعذرة، هذه الصفحة غير موجودة.
يبدوا أننا لم ’ نستطع أن نجد ما ’ تبحث عنه. من الممكن أن يساعدك البحث.
البحث عن:
زر الذهاب إلى الأعلى
إغلاق
بحث عن
